We investigated 792 and 1154 in an in vivo murine model and found that tumor growth was significantly decreased in both MYCN amplified and non-amplified tumors following treatment with 792, but 1154 significantly decreased tumor growth in only the MYCN amplified tumors. This evidence concerns the gene MYCN and neoplasm.